Skip to main content

Table 2 Cardiac MRI parameters

From: Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study

 

Total Cohort (N = 14)

Control (N = 17)

P value

Cardiac MRI

LVEF, %

54.1 ± 9.5

69.3 ± 10.1

< 0.001

LVEDVi, ml/m2

69.3 ± 16.7

62.1 ± 15.2

0.109

LVESVi, ml/m2

32.3 ± 12.0

19.9 ± 10.9

0.001

LVMi, g/m2

93.0 ± 24.8

52.3 ± 12.9

< 0.001

GRS, %

19.2 ± 8.9

36.3 ± 7.7

< 0.001

GCS, %

-12.6 ± 4.3

-19.7 ± 2.7

< 0.001

GLS, %

-8.7 ± 3.3

-17.2 ± 3.4

< 0.001

Native T1 Mapping, ms

1159.5 ± 53.0

1020.8 ± 37.3

< 0.001

ECV, %

51.5 ± 8.9

26.1 ± 3.1

< 0.001

  1. Abbreviations: LVEF = left ventricular ejection fraction; LVEDVi = LV end-diastolic volume index; LVESVi = LV end-systolic volume index; LVMi = LV mass index; GRS = global radial strain; GCS = global circumferential strain; GLS = global longitudinal strain; ECV = Extracellular volume
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172